Bosch has developed a new rapid test for its Vivalytic analysis መሣሪያ to detect the SARS-CoV-2 pathogen. The test provides a reliable result in 39 minutes and is currently the fastest polymerase chain reaction (PCR) test worldwide. Bosch’s new rapid test is predestined for decentralized use in ተንቀሳቃሽ test centers at freeway service stations or in airports. Available in Europe, the CE-approved test helps relieve laboratories, and make travel and work safer again.
The test has a sensitivity of 98 percent and a specificity of 100 percent. To develop it, the Bosch subsidiary Bosch Healthcare Solutions joined forces with the German biotechnology company R-Biopharm – a leading provider of highly sensitive manual PCR tests. PCR tests are considered the gold standard of test methods.
በዓለም የመጀመሪያ - አምስት ናሙናዎችን በአንድ ጊዜ መሞከር
Bosch launched the first rapid test for its Vivalytic analysis device at the end of March, after just six weeks’ development. As a ባለ ብዙ ቁጥር test, it simultaneously checks samples for the SARS-CoV-2 virus and nine other respiratory diseases in two and a half hours and is available in the Middle East. The new, accelerated test is exclusively for SARS-CoV-2.
ቪቫሊቲክ ትንተና መሳሪያ በፈተናው ቦታ ለመጠቀም ቀላል ነው
The advantages of Bosch’s rapid test lie not only in speedy analysis but also in የአጠቃቀም ቀላልነት. A sample is taken from the patient’s nose or throat using a swab and placed in the test cartridge. Then the test cartridge, which already contains all the reagents required for the test, is inserted into the Vivalytic device for automated analysis.
የቪቫሊቲክ ትንተና መሣሪያው ለተጠቃሚ ምቹ እንዲሆን ተደርጎ የተሠራ ነው; የሕክምና ሠራተኞች የሚሠሩት እንዴት እንደሚሠራ አጭር ሥልጠና ብቻ ነው ፡፡ የትንታኔ መሳሪያ እና የሙከራ ካርትሬጅ ያካተተው የቪቫሊቲክ ስርዓት ልማት በቦሽ ኮርፖሬት ምርምር እና በቅድመ ምህንድስና እና በቦሽ የጤና እንክብካቤ መፍትሄዎች መካከል ከረጅም ጊዜ ትብብር የመነጨ ነው ፡፡
As demand for the analysis device and the rapid tests remains high, the company is working closely with its suppliers to maximize capacity and further increase supply.